Physician
Urology
Dr. Adam R. Metwalli, MD
|
|
Give Review
Adam Metwalli is an expert in the field of Urology. He went to Wake Forest School of Medicine. He received awards:"Fellow (FACS)". Adam R. Metwalli, MD is also published. He has 23 publications published. The lastest publication: "PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.'
Publications
- PET/CT imaging of Renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
- Nephron-sparing surgery for multifocal and hereditary Renal tumors.
- Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review.
- Germline PTEN Mutation Cowden Syndrome: An Under-Appreciated Form of Hereditary Kidney Cancer.
- Germline BAP1 mutation predisposes to familial clear-cell Renal cell carcinoma.
- Diagnosis and management of BHD-associated kidney Cancer.
- Succinate dehydrogenase kidney Cancer: an aggressive example of the warburg effect in Cancer.
- Economic burden of repeat renal surgery on solitary Kidney-do the ends justify the means? A cost analysis.
- Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial Cancer cells.
- Congenital midureteral stricture in children diagnosed with antenatal Hydronephrosis.
- Visual impairment after laparoscopic donor nephrectomy.
- Tissue engineering in urology: where are we going?
- Inguinal hernia after laparoscopic orchiopexy.
- The practice of Urethral dilation for voiding dysfunction among fellows of the Section on Urology of the American Academy of Pediatrics.
- Commentary on: "Focal cryosurgical ablation of the Prostate: A single institute's perspective".
- Robotic partial nephrectomy for Renal hilar tumors: a multi-institutional analysis.
- Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in p...
- Sclerosing mesenteritis progressing to Ureteral obstruction.
- Screening and identification of differentially expressed transcripts in circulating cells of prostate Cancer patients using suppression subtractive hybridization.
- A validated mouse model for orthotopic Bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
- Controversial issues and optimal management of stage T1G3 Bladder cancer.
- Validating Bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis.
Schools
Wake Forest University School of Medicine
Procedures Preformed
- AdRenalectomy
- Cystotomy
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Renal Transplant and Nephrectomy
- View All
Conditions Treated
- Bladder Cancer
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- Diverticulum of Bladder
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
University of Oklahoma Health Sciences Center -
University of Louisville -
Wake Forest School of Medicine
Hospital
-
Howard County General Hospital -
University of Maryland Baltimore Washington Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. David M. Fenig, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parvez I. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victoria R. Staiman, MD
This Doctor is OpenDoctor Recommended.
|